Search

Zimmer Biomet Holdings Inc

Fermé

SecteurSoins de santé

95 0.81

Résumé

Variation du prix de l'action

24h

Actuel

Min

95

Max

95.82

Chiffres clés

By Trading Economics

Revenu

-39M

200M

Ventes

90M

2.2B

P/E

Moyenne du Secteur

23.432

56.432

BPA

2.07

Rendement du dividende

1.03

Marge bénéficiaire

9.169

Employés

17,000

EBITDA

-210M

328M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+11.23% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

1.03%

2.27%

Prochains Résultats

4 nov. 2026

Date du Prochain Dividende

30 oct. 2026

Date du Prochain Détachement de Dividende

29 sept. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-348M

18B

Ouverture précédente

94.19

Clôture précédente

95

Sentiment de l'Actualité

By Acuity

25%

75%

28 / 339 Classement par Healthcare

Zimmer Biomet Holdings Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 sept. 2026, 21:51 UTC

Zimmer Biomet Holdings, Inc. is advancing in after-market trading, moving higher alongside the broader market despite concerns over U.S. economic momentum.

16 sept. 2026, 20:07 UTC

Zimmer Biomet Holdings, Inc. shares fell sharply, retracing from earlier gains and remaining below the 20-day moving average amid a decline since Tuesday's close.

15 sept. 2026, 20:03 UTC

Zimmer Biomet shares are higher today, continuing positive momentum from Monday. This follows an early dip amid broader market concerns over New York's manufacturing sector.

14 sept. 2026, 22:01 UTC

Zimmer Biomet Holdings shares are higher in after-market trading, continuing a trend of gains since Monday's close. No specific news was identified.

11 sept. 2026, 23:46 UTC

Zimmer Biomet Holdings shares advanced in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

10 sept. 2026, 20:03 UTC

Zimmer Biomet Holdings is declining during Thursday's session, continuing a downward trend since Wednesday's close with no specific news identified for the movement.

9 sept. 2026, 22:51 UTC

Zimmer Biomet Holdings is trading lower in after-market hours amid a broader decline in U.S. stocks linked to rising crude oil prices above $100.

8 sept. 2026, 21:02 UTC

News

Zimmer Biomet announced leadership promotions to enhance its strategy and reaffirmed its 2026 financial outlook. Shares are higher in after-market trading.

4 sept. 2026, 20:07 UTC

Shares of Zimmer Biomet Holdings are lower today, amid increased selling pressure following a strong jobs report. The stock remains below its 20-day moving average.

2 sept. 2026, 20:08 UTC

Zimmer Biomet shares are higher today, benefiting from significant advances in Health Care Equipment stocks. No specific news was identified to explain the movement.

1 sept. 2026, 21:51 UTC

Zimmer Biomet Holdings shares are higher in after-market trading, nearing the top of their one-month range, amid broader market volatility and rising crude oil prices.

31 août 2026, 20:07 UTC

Shares of Zimmer Biomet Holdings are trading lower amid market pressure from heightened interest rate hike expectations following the Jackson Hole Economic Symposium.

28 août 2026, 19:16 UTC

Zimmer Biomet Holdings is trading higher during Friday's session, maintaining a position above its 20-day moving average and near the upper end of its one-month range.

27 août 2026, 20:02 UTC

Zimmer Biomet Holdings, Inc. shares are lower as Health Care Equipment stocks face pressure, marking a shift from recent upward trends. No specific news was identified.

26 août 2026, 19:26 UTC

Zimmer Biomet Holdings is trading higher, supported by strength above its 20-day moving average amid broader market dynamics and rising U.S. consumer prices.

25 août 2026, 23:31 UTC

Zimmer Biomet Holdings is trading lower in after-market hours. This decline comes amid broader market sentiment impacted by a significant drop in crude oil prices.

24 août 2026, 19:46 UTC

Zimmer Biomet Holdings is trading higher today, with shares near the upper end of their one-month range amid rising oil prices and geopolitical tensions.

22 août 2026, 00:01 UTC

Zimmer Biomet Holdings Inc. shares are lower in after-market hours, reflecting broader weakness despite remaining above the 20-day moving average.

21 août 2026, 23:01 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours, with no specific news identified. Recent bond market volatility may be influencing trader sentiment.

19 août 2026, 20:06 UTC

Zimmer Biomet Holdings Inc is trading higher today, marking a shift from its recent trend of higher daily closes since Tuesday. No specific news was identified.

18 août 2026, 19:16 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. reported first-quarter revenue of $2.05 billion, exceeding estimates. Shares are advancing amid raised full-year guidance and positive sector sentiment.

17 août 2026, 20:02 UTC

Zimmer Biomet Holdings Inc shares are lower today, continuing a decline since Friday amid broader market pressures and rising crude oil prices.

14 août 2026, 19:26 UTC

News

Zimmer Biomet Holdings Inc. shares are higher following Q2 earnings that topped estimates, with revenue of $2.18 billion and adjusted EPS of $2.07.

13 août 2026, 19:46 UTC

Shares of Zimmer Biomet Holdings are trading higher, remaining strong near the upper end of their one-month range amid positive broader market sentiment.

12 août 2026, 23:21 UTC

Zimmer Biomet Holdings Inc. shares are roughly flat in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

11 août 2026, 23:02 UTC

Zimmer Biomet Holdings Inc. shares are higher in after-market trading, moving within a range above its 20-day moving average and near a one-month high.

10 août 2026, 19:56 UTC

Correlated Moves
News

Canaccord raised Zimmer Biomet's price target to $100 from $83, maintaining a Hold rating. Shares are higher since Friday's close amid market strength.

7 août 2026, 19:46 UTC

News

Zimmer Biomet shares are lower today as Truist maintains a Hold rating but raises the price target to $106 amid cautious market conditions.

6 août 2026, 19:52 UTC

News

Zimmer Biomet shares are lower today, despite price target increases from RBC, BMO, and Wells Fargo. This marks a shift from recent higher daily closes.

5 août 2026, 23:02 UTC

News

Stifel raised the price target on Zimmer Biomet to $110 from $105, maintaining a Buy rating. Shares are higher in after-market trading.

Comparaison

Variation de prix

Zimmer Biomet Holdings Inc prévision

Objectif de Prix

By TipRanks

11.23% hausse

Prévisions sur 12 Mois

Moyen 106.067 USD  11.23%

Haut 120 USD

Bas 93 USD

Basé sur 18 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

18 ratings

6

Achat

12

Maintien

0

Vente

Sentiment

By Acuity

28 / 339Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.